Histogenesis of giant cell tumors

被引:0
作者
Wuelling, M [1 ]
Engels, C [1 ]
Jesse, N [1 ]
Werner, M [1 ]
Kaiser, E [1 ]
Delling, G [1 ]
机构
[1] Univ Hamburg, Krankenhaus Eppendorf, Abt Osteopathol, Zentrum Biomech, D-20251 Hamburg, Germany
来源
PATHOLOGE | 2002年 / 23卷 / 05期
关键词
giant cell tumor of bone; bone neoplasm; osteoclast; review;
D O I
10.1007/s00292-002-0552-2
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The giant cell tumor of bone (GCT) is a local osteolytic tumor with variable degrees of aggressiveness. In rare cases pulmonary metastases can be observed. The lesion most frequently occurs in the epiphysis of long tubular bones of the knee region, predominantly affecting young adults after closure of the growth plate. The characteristic histological appearance of GCT displays a high number of osteoclast-like multinucleated giant cells, which resulted in the classification "osteoclastoma" or "giant cell tumor". Apart from the multinucleated giant cells,there are two mononuclear cell types in the GCT. The first one has a round morphology and resembles a monocyte. The second cell type is the spindle-shaped,fibroblast-like stromal cell. Cell culture experiments with GCT cells revealed the stromal cell to be the proliferating component of the GCT. The other two cell types, the monocyte and the multinucleated giant cell, were lost after a few cell culture passages. Furthermore, latest results from GCT reveal that the stromal cells secrete a variety of cytokines and differentiation factors, including MCPI,ODF and M-CSF. These molecules are monocyte chemoattractants and are essential for osteoclast differentiation, suggesting that the stromal cell stimulates blood monocyte immigration into tumor tissue and enhances their fusion into osteoclast-like, multinucleated giant cells. The multinucleated giant cell itself demonstrates properties of a normal osteoclast that is able to resorb bone leading to extended osteolysis. This new model of GCT genesis supports the hypothesis that the stromal cell is the neoplastic component whilst the monocytes and the multinucleated giant cells are just a reactive component of this tumor. Taking this into consideration, the nomenclature of the "giant cell tumor" needs to be reconsidered.
引用
收藏
页码:332 / 339
页数:8
相关论文
共 68 条
[1]  
ABE EMH, 1998, CALCIFIED TISSUE INT, V64, P508
[2]   The prognostic significance of DNA cytophotometry and proliferation index (Ki-67) in giant cell tumors of bone [J].
Antal, I ;
Sápi, Z ;
Szendröi, M .
INTERNATIONAL ORTHOPAEDICS, 1999, 23 (06) :315-319
[3]   Expression of osteoclast differentiation signals by stromal elements of giant cell tumors [J].
Atkins, GJ ;
Haynes, DR ;
Graves, SE ;
Evdokiou, A ;
Hay, S ;
Bouralexis, S ;
Findlay, DM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) :640-649
[4]   Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation [J].
Atkins, GJ ;
Haynes, DR ;
Geary, SM ;
Loric, M ;
Crotti, TN ;
Findlay, DM .
BONE, 2000, 26 (06) :653-661
[5]   CHROMOSOMAL-ABNORMALITIES IN GIANT-CELL TUMORS OF BONE [J].
BARDI, G ;
PANDIS, N ;
MANDAHL, N ;
HEIM, S ;
SFIKAS, K ;
WILLEN, H ;
PANAGIOTOPOULOS, G ;
RYDHOLM, A ;
MITELMAN, F .
CANCER GENETICS AND CYTOGENETICS, 1991, 57 (02) :161-167
[6]  
Bay JO, 1999, REV RHUM, V66, P49
[7]  
BERTONI F, 1988, CLIN ORTHOP RELAT R, P275
[8]   Metalloprotease-disintegrins: Links to cell adhesion and cleavage of TNF alpha and notch [J].
Blobel, CP .
CELL, 1997, 90 (04) :589-592
[9]  
BRIDGE JA, 1990, CANCER, V65, P2697, DOI 10.1002/1097-0142(19900615)65:12<2697::AID-CNCR2820651217>3.0.CO
[10]  
2-3